Slight (1)quinupristin/dalfopristin will boost the level or outcome of paclitaxel protein bound by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Unfamiliar.

quinupristin/dalfopristin will lower the extent or result of pyridoxine by altering intestinal flora. Applies only to oral type of each brokers. Slight/Importance Unidentified.

quinupristin/dalfopristin will lower the extent or influence of estradiol by altering intestinal flora. Applies only to oral varieties of hormone. Reduced danger of contraceptive failure. Use Warning/Monitor.

quinupristin/dalfopristin will boost the degree or influence of digoxin by altering intestinal flora. Applies only to oral method of both brokers. Use Warning/Keep an eye on.

It is best to bring this record with you each time you pay a visit to a doctor or When you are admitted to some healthcare facility. It is additionally crucial information to carry with you in the event of emergencies.

Publisher’s Notice Springer Mother nature continues to be neutral regarding jurisdictional statements in released maps and institutional affiliations.

quinupristin/dalfopristin will boost the level or effect of sufentanil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Unfamiliar.

quinupristin/dalfopristin will increase levels of erythromycin ethylsuccinate by decreasing metabolism. Contraindicated. Threat of prolonged QTc interval.

quinupristin/dalfopristin will boost the amount or outcome of erythromycin ethylsuccinate by affecting hepatic/intestinal enzyme Quinupristin CYP3A4 metabolism. Stay clear of or Use Alternate Drug.

quinupristin/dalfopristin will raise the stage or outcome of norgestrel by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on. Strong or moderate CYP3A4 inhibitors may possibly increase systemic concentration of norgestrel, which can improve chance for adverse consequences

quinupristin/dalfopristin will enhance the degree or outcome of conjugated estrogens by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.

quinupristin/dalfopristin will raise the level or influence of bortezomib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.

quinupristin/dalfopristin decreases results of sodium picosulfate/magnesium oxide/anhydrous citric acid by altering metabolism. Use Warning/Keep an eye on. Coadministration with antibiotics decreases efficacy by altering colonic bacterial flora required to transform sodium picosulfate to Lively drug.

quinupristin/dalfopristin will boost the amount or result of midazolam intranasal by affecting hepatic/intestinal enzyme CYP3A4 metabolism.